Clin2
NCT07788430Possibly a fitNot yet recruiting

Pesticide exposure and survival in glioblastoma

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Part of Cancer clinical trials.

This study looks at whether exposure to pesticides affects how the tumor behaves and how long people live after a glioblastoma diagnosis. By joining, you help researchers learn if environmental factors matter for this brain cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years of age or older.
  • You have been newly diagnosed with an IDH wild-type glioblastoma (a common type of brain tumor).
  • You have not yet started treatment for the glioblastoma (such as radiation with chemo, or chemo combined with targeted therapy).
  • You must sign a consent form agreeing to take part.
  • You must be willing to follow the study procedures.
  • You have French national health insurance.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06222138Recruiting
Biomarker study of TTFields in newly diagnosed glioblastoma

This trial looks at how well Tumor Treating Fields (TTFields) therapy works for people with newly diagnosed glioblastoma. Researchers will study blood and tumor samples to find markers that might predict how well the treatment works.

Toulouse
NCT05541042Not yet recruiting
Brain scans to predict genetics of glioblastoma

This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.

Zhengzhou, Henan
NCT05326334Recruiting
Study gut microbiome in new glioblastoma patients

This trial studies how changes in gut bacteria (gut microbiome) relate to outcomes in people with newly diagnosed glioblastoma receiving standard chemo-radiation. It may help doctors learn which gut-bacteria patterns go along with better or worse results during treatment.

Ottawa, Ontario
NCT05941234Recruiting
Studying stem cells and blood patterns in glioblastoma

This study analyzes tissue and health-related biological data from people with glioblastoma to learn what’s happening in the tumor. The results may help improve future ways to understand and treat glioblastoma using advanced computer analysis.

Rome
NCT06625684Recruiting
Long-term study for glioblastoma patients

This study tracks people with glioblastoma (a type of aggressive brain tumor) over time to understand what affects their health and quality of life. If you take part, you'll fill out online surveys to help researchers learn how to improve care.

Durham, North Carolina
NCT07472387Not yet recruiting
Study on how male hormones affect immune cells in glioblastoma

This study looks at how male hormones (androgens) affect the immune cells around glioblastoma tumors. Researchers will analyze tumor tissue left over from surgery to learn more, which may help improve future treatments.

Paris

Hear when a new Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.